| |
| HEALTHCARE |
Patient Safety Movement Foundation Appoints New Chairman; Announces Drive Toward Zero Preventable Patient Deaths By 2030
March 12, 2020
Patient Safety Movement Foundation (PSMF) – a global non-profit dedicated to unifying those involved in the healthcare ecosystem, identifying challenges that are causing patient deaths, and creating actionable solutions to mitigate them – is pleased to announce the appointment of its new chairman of the board of directors – Michael A.E. Ramsay, MD, FRCA. It also reaffirms its commitment to patient health and safety with updates to its mission, vision and values; and reestablishes its goal of achieving ZERO preventable patient deaths by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200310005733/en/ As one of PSMF’s longest-standing board members, serving since 2013, Dr. Ramsay has been an advocate for patient safety in the anesthesia world since the 1980’s and embodies the values and principles......
Japan Contributes $4.4 Million to Support UNICEF’s Health, Nutrition Programmes
March 12, 2020
BAGHDAD (UNICEF) — Japan has contributed US $ 4.4 million to support UNICEF’s health and nutrition programmes for some of Iraq’s most vulnerable children and their families. The grant will target population in displacement camps as well as seven governorates impacted by conflict and displacement, including Dohuk, Erbil, Suleimaniyah, Kirkuk, Ninewah, Salahaddin, and Anbar. “Japan"...
Sulaimani Health Directorate advises residents to stay home to prevent further spread of coronavirus
March 12, 2020
SULAIMANI — Sulaimani Health Directorate Spokesperson Yad Naqshbandi said on Wednesday (March 11) that the government was advising city residents to stay at home and avoid going out to crowded places because of fears that if coronavirus spreads any further then it will become more difficult to contain. “Although we have taken measures to prevent the spread of the virus, the population is not following regulations,” Naqshbandi said. "...
Coronavirus: KRG bans non-emergency travel between provinces
March 12, 2020
ERBIL, Kurdistan Region – Non-emergency travel between provinces has been banned by the Kurdistan Regional Government (KRG) from March 14 to 28 in a bid to contain the spread of coronavirus, according to an interior ministry statement.
“Medical teams, diplomats, organizations, UN-affiliated agencies, security forces, and businessmen” are exempt from the movement ban, according to the statement, seen by Rudaw.
Emergency travel by non-exempt groups and individuals “requires"...
The mask shortage may get worse as coronavirus outbreak intensifies
March 12, 2020
Michael Einhorn’s medical supply company may run out of the masks used to protect against coronavirus in two weeks unless the Chinese manufacturer of his branded equipment resumes production this week. “We’re having to make tough decisions every day on who gets masks and who doesn’t,” said Mr Einhorn, the founder of New York-based Dealmed-Park Surgical, which employs almost 100 people. “Do masks go to the suburban"...
Vifor Pharma Group Reports Strong Growth in 2019, Exceeding Raised Guidance
March 12, 2020
Regulatory News: Vifor Pharma Group recorded strong financial and operational performance in 2019 by focusing on its three strategic growth drivers while continuing to invest in its pipeline. The company exceeded its raised guidance for full-year 2019 on both net sales and EBITDA. FINANCIAL PERFORMANCE: STRONG SALES AND PROFIT GROWTH CONTINUES
Erbil to suspend plastic surgeries in private hospitals
March 11, 2020
SULAIMANI — The Erbil General Health Directorate on Tuesday (March 10) decided to suspend all plastic surgeries in private hospitals indefinitely. In a directive sent to all private hospitals the Health Directorate said to “suspend all plastic surgeries in the private hospitals and clinics indefinitely following regulations against the coronavirus.” “Any"...
Takeda Provides Update on TOURMALINE-MM2 Phase 3 Trial
March 11, 2020
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the results from the TOURMALINE-MM2 study designed to evaluate the addition of NINLARO™ (ixazomib) to lenalidomide and dexamethasone in newly diagnosed transplant ineligible multiple myeloma patients. The addition of ixazomib to lenalidomide and dexamethasone resulted in an improvement in median progression-free survival (PFS) of 13.5 months (35.3 months versus 21.8 months; hazard ratio [HR] 0.83; p=0.073); however, it did not meet the threshold for statistical significance. The safety profile associated with NINLARO from the TOURMALINE-MM2 trial was generally consistent with the existing prescribing information. Results from the TOURMALINE-MM2 study will be submitted to an upcoming medical congress. “There is a need for treatment options in transplant ineligible patients. We remain......
Sinterex named Best 3D-Printed Healthcare Products Manufacturer Middle East
March 11, 2020
Global Health & Pharma (GHP), a global information sharing platform & a multi-disciplinary members community announced winners of the 2019 Technology Awards this month and recognised Sinterex as Best 3D-Printed Healthcare Products Manufacturer – Middle East. In its announcement, GHP said, “Technology is a great force for change across numerous industries, sectors and fields. In the global healthcare industry, it has become a"...
IMF calls for 'substantial' stimulus against coronavirus
March 10, 2020
WASHINGTON — Governments should deploy 'substantial' stimulus and international coordination to counteract the economic impact of the spreading coronavirus epidemic, the International Monetary Fund's chief economist said Monday.
Given the 'acute shocks' caused to economies, consumers and businesses, Gita Gopinath said 'policymakers will need to implement substantial targeted fiscal, monetary and financial market measures to help affected households and businesses.'
...
|
|
|
|
|